Haplo2Ped: a tool using haplotypes as markers for linkage analysis by Cheng, Feng et al.
SOFTWARE Open Access






1 and Changqing Zeng
1*
Abstract
Background: Generally, SNPs are abundant in the genome; however, they display low power in linkage analysis
because of their limited heterozygosity. Haplotype markers, on the other hand, which are composed of many SNPs,
greatly increase heterozygosity and have superiority in linkage statistics.
Results: Here we developed Haplo2Ped to automatically transform SNP data into haplotype markers and then to
compute the logarithm (base 10) of odds (LOD) scores of regional haplotypes that are homozygous within the
disease co-segregation haploid group. The results are reported as a hypertext file and a 3D figure to help users to
obtain the candidate linkage regions. The hypertext file contains parameters of the disease linked regions,
candidate genes, and their links to public databases. The 3D figure clearly displays the linkage signals in each
chromosome. We tested Haplo2Ped in a simulated SNP dataset and also applied it to data from a real study. It
successfully and accurately located the causative genomic regions. Comparison of Haplo2Ped with other existing
software for linkage analysis further indicated the high effectiveness of this software.
Conclusions: Haplo2Ped uses haplotype fragments as mapping markers in whole genome linkage analysis. The
advantages of Haplo2Ped over other existing software include straightforward output files, increased accuracy and
superior ability to deal with pedigrees showing incomplete penetrance. Haplo2Ped is freely available at: http://
bighapmap.big.ac.cn/software.html.
Background
Linkage analysis plays an important role in mapping dis-
ease-causing genes. Compared to other methods, such as
association research, not only are very limited samples
needed in linkage study, but also the high disease homoge-
neity among pedigree members increases the possibility of
locating causative genes [1,2]. Furthermore, linkage map-
ping of complex traits was made feasible for experimental
organisms, such as animals and plants, through the use of
genetic mapping in large crosses [3,4]. Linkage analysis
has wide applications in both medical experiments and
agricultural breeding.
Along with the achievement of high-throughput SNP
genotyping, using whole genome SNP data for linkage
analysis has been shown to be an efficient strategy [5,6].
However, because of their two-allele character, the
heterozygosity of SNP markers is usually lower than tra-
ditional genetic markers, such as short tandem repeats
(STRs). Therefore, two point linkage analysis with SNP
data is often insufficiently powerful. Considering the
abundance of SNPs in the human genome, the use of
multi-point based methods, such as haplotype-disease
co-transmission analysis, would largely overcome the
low heterozygosity of individual SNPs, because haplo-
types formed by multi SNPs could easily achieve the
maximum heterozygosity in pedigrees.
Software packages have been developed to carry out
multi-point analysis. The traditional linkage methods
employed two basic algorithms: the Elston-Steward algo-
rithm, used in Allegro, and the Lander-Green algorithm,
used in Merlin. SNPLINK, a Perl Script that performs full
genome linkage analysis, uses both these algorithms.
However, the application of these two algorithms is lim-
ited, either by the number of markers or by the size of
the pedigrees. Another program, SNP4Linkage, is based
on allele sharing determination and is better adapted to
high-density SNP genotyping data. Nevertheless, it still
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mic markers for linkage research [7-10]. Therefore, Hap-
lo2Ped was developed. It can perform whole genome
linkage analysis with haplotypes and generate a corre-
sponding report file that contains linkage regions, LOD
scores, and the candidate genes. To help users to obtain
further information, links for the candidate genes to data-
bases of gene annotations and OMIM (Online Mendelian
Inheritance in Man) are also offered [11]. Meanwhile, an
auto-generated 3D picture allows users to visualize the
linking signals clearly on a genomic scale.
Implementation
Haplo2Ped is an effective tool using haplotypes as mar-
kers for linkage analysis. It is well-suited for genome-
wide linkage mapping with high density SNP data. It pro-
vides a user-friendly interface to select input files and set
parameters to perform the analysis (Figure 1). The Run-
Time Reports illustrate the processing phases of the
entire analysis. For the algorithm, it divides the studied
family into several small nuclear trios (father, mother,
and one child) (Figure 2A). The parental haplotypes of a
haploid gamete can then be deduced from the genotype
data of these trios, according to Mendelian inheritance
rules. During this process, SNPs showing Mendelian
errors are automatically removed. Genotypes that are
heterozygous in all three members of a trio are treated as
uninformative data, because it is difficult to phase the
haplotype at these sites in this trio. Based on the affected
status and the inheritance model, the parental haplotypes
that co-segregate with the disease are selected and
named as aHaps (affected haploids) (Figure 2A). These
aHaps are then submitted for haplotype sharing analysis.
Firstly, we consider the example of a dominant disease
model. In a trio, if the child and his father are both
affected, the father’s transmitted haploid will be selected
as an aHap. Conversely, if the child is healthy, the
affected father’s untransmitted haploid will be deemed
as an aHap. When we cannot be sure of the child’s
affected status (the child is too young to show symp-
toms or it is a disease with incomplete penetrance),
then the affected father’s two chromatids would be
selected and treated with the rule that at least one of
them is an aHap.
Once the set of aHaps is determined from all the trios,
the haplotype sharing analysis is performed. A window-
length and step-size are set to scan these aHaps to
determine disease candidate segment(s) generated from
Figure 1 The user-friendly interface of Haplo2Ped. Users select input files and set parameters on the left side. The Run-Time Reports on the
right side indicate the ongoing step of the process.
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Page 2 of 8Figure 2 The nuclear trios division and haplotype sharing analysis.( A) The family is divided into three nuclear trios (father, F; mother, M;
child, C). Parental haplotypes are then deduced from the genotype data of these trios. The one co-segregating with the disease is named as an
aHap (affected haplotype) and submitted into homozygosity analysis. (B) A windows slides along the whole genome to determine homozygous
fragments. LOD scores are calculated using homozygous aHap regions as markers. Bars represent chromosomes; the black region is the causal
mutation of the disease; red crossovers between parental chromosomes denote recombination events; the designed affected status is shown by
filled circles/boxes for affected and open circles/boxes for unaffected.
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locating within the same scanning window, if they show
homozygosity in all aHaps, this window would be
merged with the adjacent homozygous windows until
the sliding window process moves out of the area show-
ing homozygosity. After the completion of aHap scan-
ning, the family’s haplotype fragments that are located
in the homozygous aHap regions are determined and
are consequently used as markers to calculate LOD
scores [12].
For a disease with incomplete penetrance, we cannot
determine whether the asymptomatic healthy child is
really disease free or not. As referred to above, we treat
both the transmitted and un-transmitted haploids of
their affected parent as paired aHaps. The two assumed
aHaps are then compared to the assured aHaps. A true
disease co-segregation haplotype fragment should be
found in at least one of the two assumed aHaps. Regard-
ing determination of a candidate region by window slid-
ing, although paired aHaps are not as informative as the
assured aHaps, they may still contribute to shortening
the linked regions and identifying whether or not the
child carries the disease targeted haplotype.
Using the above method to analyze a disease caused
by fragment deletion may result in two linked regions
separated by a homozygous region caused by the dele-
tion. For large deletions (> 500 Kb), such a result may
lead to confusion or an incorrect conclusion. Therefore,
Haplo2Ped provides a LOH (loss of heterozygous) test
to detect large fragment deletions.
Results
We used the pedigree data generated from Illumina 370
K CNV-Quad chip as an example for analysis. The raw
dataset came from a family with RP (retinitis pigmen-
tosa) disease. To test Haplo2Ped, we made certain
changes in the raw data to generate simulated disease
targets. The pedigree structure is shown in Figure 3. Six
independent chromosome regions were assumed to
carry the mutations (Expected Regions in Table 1). They
Figure 3 The pedigree structure of the simulated example. Squares (males) and circles (females) filled with black indicate affected members.
Individual 2 is the disease founder. The disease is assumed to fit an autosomal dominant model with complete penetrance. Bars denote
chromosome groups of each member; red bars are groups that were simulated to take the disease-causal mutations (black regions); other
colored bars, including green and light brown, are the unaffected chromosome groups.
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in chromosome 1, 5, 9, 13, 17, and 21, respectively. For
the two regions in chromosome 17 and 21, crossovers
were deliberately designed in the middle of them.
Therefore, the final sizes of the disease carrying haplo-
t y p e sw e r e1 ,3 ,4 ,5 ,4 ,a n d5M b( s e ea d d i t i o n a lf i l e1 :
The pedigree simulation process).
The genotype data of the simulated pedigree was then
submitted to Haplo2Ped for linkage mapping. Figure 4
shows the linkage signals across the whole genome
detected by this tool. All the six assumed regions were
identified with a LOD score of 3.010, the maximum value
at the genome-wide level. No other regions showed such
a large LOD score, indicating that no false positives were
generated by Haplo2Ped in this simulated analysis (see
additional file 1: The pedigree simulation process). As
shown in Table 1, these expected candidates are comple-
tely included in the regions found by Haplo2Ped, and
each of the detected candidate regions is only slightly lar-
ger than the simulated region, suggesting that Haplo2Ped
is reliable, sensitive, and accurate.
To compare the efficiency of Haplo2Ped with other
existing software, we submitted the same simulated data
t oM e r l i n ,S N P L i n k ,a n dS N P 4 L i n k a g e .T h eo u t p u t
results are listed in Table 1. Merlin reported the six
regions co-segregating with the disease with a LOD score
of around 1.78, which was the maximum value across the
whole genome. Four of these six reported regions were
smaller than the expected regions indicating that some
regions that might harbor the disease-causal mutation
were missed. Such a low LOD score could not reflect the
real level of linkage between the disease-causal regions
and the disease phenotype. Except for the six simulated
regions, Merlin also detected three other regions with
LOD scores of around 1.78 (Table 1). These false positive
results could add to the difficulty in locating the disease-
causing mutations in real studies. Moreover, Merlin
reported the LOD score of every individual SNP. The
LOD scores of SNPs on the border of the linked regions
usually increase from a low value of unlinked regions to a
high value of linked regions or decrease the other way
around. Thus, another concern is that it is usually diffi-
cult for users to determine the borders of the regions
detected by Merlin.
SNPLINK did not report LOD scores in the final out-
put files although it showed good accuracy on four
regions co-segregating with the disease. Furthermore,
S N P L I N Km i s s e ds o m er e g i o n so nt h el e f te d g eo ft w o
expected regions on chromosomes 1 and 13. The results
from SNP4Linkage were the same as SNPLINK. There
were no false positive regions detected by these two
programs.
In a real study of a digital-anomaly family, we applied
Haplo2Ped to SNP genotype data from 13 family mem-
bers for the linkage analysis by haplotype, and success-
fully located the linkage region. Further study
determined the mutation of the causative gene [13].
Comparisons of Haplod2Ped and other existing software
using the data from the real study are listed in additional
file 2: Software comparisons using real data. All the soft-
ware packages successfully located the disease-causing
region, while Merlin reported more false positive regions.
To evaluate the false positive rate of Haplo2Ped, we
simulated genotype data sets for thirty pedigrees with one
causal mutation each using an in-house developed Perl
script (packaged with Haplo2Ped). Each data set was ana-
lyzed by both Haplo2Ped and Merlin. The false positive
regions reported by Merlin were significantly more than
those reported by Haplo2Ped (Figure S1 in additional file
3: Evaluation of false positive rate of Haplo2Ped with com-
pletely simulated genotype data), indicating that using
haplotypes that are of high heterozygosity as markers has
better efficiency in filtering false positive regions than
using only individual SNPs.
Table 1 Simulated linkage regions and the regions detected by Haplo2Ped
Haplo2Ped Merlin
Chr Expected region
a(bp) Detected region (bp) LOD score Detected region (bp) LOD score SNPLINK
b
1 216,655,820-217,662,693 216,631,505-217,703,573 3.010 216,907,787-217,662,692 1.773 217,005,036-217,668,715
5 38,764,018-41,787,459 38,631,518-42,305,421 3.010 38,854,039-41,712,049 1.777 38,886,647-42,163,690
9 27,316,060-31,341,194 27,143,875-31,616,167 3.010 27,319,623-31,394,530 1.777 27,306,972-31,369,980
13 96,346,535-101,352,382 96,316,072
101,404,566
3.010 96,328,971-101,304,534 1.778 96,836,579-101,356,932
17 50,661,600-54,645,983 50,621,012-54,818,763 3.010 50,690,828-58,850,202 1.804 50,661,601-54,726,213
21 21,812,513-26,812,202 21,781,794-27,090,473 3.010 21,833,903-26,812,201 1.778 21,812,514-26,818,797
1 / / / 55,489,086-62,400,262 1.778 /
5 / / / 10,529,760- 11,796,160 1.778 /
9 / / / 73,498,210- 80,047,165 1.778 /
aExpected region, the simulated region assumed to contain disease mutations.
bRegions detected by SNP4Linkage were the same as those reported by SNPLINK.
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The haplotype-sharing scanning of aHaps is the most
important step in Haplo2Ped. For dominant diseases,
the main point is to confirm whether the disease hap-
loid is transmitted or not. In the case of recessive dis-
eases, two haplotypes of the affected individual are both
aHaps. Additionally, for either a dominant or recessive
model, Haplo2Ped is only suitable for one-disease-foun-
der cases (i.e. a disease with complete homogeneity).
Two or more disease founders would result in more
than one type of disease haplotype for the family, which
could lead to either loss of linkage signals, or generate
false positives. Haplo2Ped analysis is based on deduced
parental haplotypes; therefore, in cases where one parent
is missing in a nuclear family, it is still applicable for
linkage study.
Our simulation analysis showed that Haplo2Ped was
consistently accurate in pinpointing the regions co-segre-
gating with the disease. It did not miss any expected
regions, while other software reported biased results,
especially on the left edge of certain regions. Given the
limited recombination events accumulated in a pedigree,
both the disease-causing mutation and the neighboring
SNPs in a shared haplotype co-segregate with the disease
phenotype. However, when a disease-causing haplotype is
transmitted to offspring, recombination occurs at ran-
dom sites of this haplotype, indicating that the disease-
causing mutation also probably locates at the edge of our
assumed regions. If any expected regions are missed, the
risk of not locating the final mutation is increased.
A gain of LOD score using haplotypes as markers in
our tool demonstrated an advantage over Merlin, which
Figure 4 Graphical report of the Haplo2Ped application. The x- and y-axes represent the individual autosomes and their physical positions,
respectively. The z-axis shows the LOD scores of each linkage region. The regions with the maximum LOD scores are labeled with arrowheads
and others are labeled with circles at the top. In this example, all assumed regions were detected by Haplo2Ped with the highest LOD scores in
chromosomes 1, 5, 9, 13, 17, and 21.
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Employing haplotypes with high heterozygosity as
markers avoided the false positive results generated by
Merlin, which is subject to the low heterozygosity of
individual SNPs. Furthermore, the LOD score of the
SNPs reported by Merlin in the assumed regions usually
varies over a wide range. Many SNPs even show lower
LOD scores than those in the unlinked regions. This
adds to the difficulty of locating the linked regions.
Thus, we suggest that our method of combining the het-
erozygosity of multi-SNPs and the breakpoints of
recombination (borders of co-segregating haplotype)
better reflects the stable strength of a linkage region
compared to a method that only uses the heterozygosity
of individual SNPs.
Another advantage of Haplo2Ped is its capability of
dealing with the diseases that exhibit incomplete pene-
trance, a model of which is not included in software
such as SNPLINK. Using simulated data with incom-
plete penetrance, although Merlin reported expected
linkage regions similar to those of Haplo2Ped (addi-
tional file 4: Software comparison with simulation data
with incomplete penetrance), it generated three false
positive regions, while Haplo2Ped reported none. Perfor-
mance on the data from the real study with incomplete
penetrance and the simulated genotype data of thirty
pedigrees also showed that Merlin reported more false
positive regions than Haplo2Ped. In addition, using the
notion of shared affected haploids among affected indi-
viduals instead of traditional algorithms, such as the
Elston-Steward and the Lander-Green algorithms means
that Haplo2Ped is not restricted by the number of mar-
kers or the family members. The successful application
of Haplo2Ped to a real study demonstrated its power in
detecting the regions harboring the disease-causing
mutation.
The haplotype-sharing analysis is sensitive to mis-gen-
otyped SNPs, which may generate false breakpoints in
the haplotype fragments. To prevent such errors, we use
a window sliding method to scan the genome. For the
haplotype fragment in each window, we determine if it is
homogeneous among all aHaps with a certain tolerance.
For example, we set the level of inconsistent SNPs to less
than 5% of the total in the above analysis. When the win-
dow steps into the linkage region, the ratio of inconsis-
tent SNPs should largely decrease and when the window
steps into the recombination free region, the ratio quickly
increases to above 5%. As the real ratio of mis-genotyped
SNPs is usually unknown or is different in different geno-
m i cr e g i o n s ,w es u g g e s tat h r e s h o l do f5 %b es e ta st h e
mis-genotype tolerance. Generally, a 5% typing error is
much higher than the true ratio in experiments, and it
would generate a candidate region slightly larger than the
real linkage region as seen in our example. Despite a
relatively conservative setting, the introduction of false
breakpoints by mis-genotyped SNPs should be prevented.
Conclusions
The new software, named Haplo2Ped, which uses haplo-
type fragments as mapping markers in whole genome
linkage analysis, has been developed. Comparison with
other programs by simulation tests and successful appli-
cation in a real study demonstrated its high efficiency
and reliability. Haplo2Ped is not restricted by the num-
ber of markers or family members. Moreover, it also
provides LOH (loss of heterozygosity) detection for ped-
igrees in which fragment deletion causes the disease.
We propose that haplotype fragments could be powerful
genomic markers in linkage analysis.
Availability and requirements
Software name: Haplo2Ped
Software home page: http://bighapmap.big.ac.cn/soft-
ware.html
Operating system(s): Windows or Linux




Additional file 1: The pedigree simulation process. The pedigree
simulation process was carried out based on a real genotype data set of
a RP (retinitis pigmentosa) family. The family members’ affected status
was reset and six disease co-segregating haplotypes were simulated in
chromosomes 1, 5, 9, 13, 17, and 21.
Additional file 2: Software comparisons using real data. Linkage
regions detected by three different softwares are from data of a real
study (Table S1). The pedigree analyzed is a three-generation Han
Chinese family with complex digital anomalies.
Additional file 3: Evaluation of false positive rate of Haplo2Ped with
completely simulated genotype data. Comparison of false positive rate
between Haplo2Ped and Merlin based on simulated genotype data of
thirty different pedigree structures.
Additional file 4: Software comparison with simulated pedigree in
incomplete penetrance. The detected regions reported by Haplo2Ped
and Merlin using simulated pedigree in incomplete penetrance.
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